A021202 Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors

Investigator: Eric Bernicker, MD

Study Coordinator: Lacey Burey

Status: Open Not Enrolling

ClinicalTrials.gov Number: NCT01841736

Phone: 713.441.1159

IRB Number: Pro00011234

Description

This randomized phase II trial studies how well pazopanib hydrochloride works in treating patients with carcinoid tumors that are growing, spreading, or getting worse. Pazopanib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
More to Explore